ALX-006

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameALX-006

Drug Alias NameALX-006ALX006

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionProgrammed death-ligand 1 blockersVascular endothelial growth factor inhibitorsAnti-PD-1

TargetsProgrammed death-ligand 1Vascular endothelial growth factorProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesAilux Biologics

China Registration ClassN/A

Develop Information

Active CompaniesAilux Biologics

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A